EA200701689A1 - Новые производные бетулиновой кислоты - Google Patents

Новые производные бетулиновой кислоты

Info

Publication number
EA200701689A1
EA200701689A1 EA200701689A EA200701689A EA200701689A1 EA 200701689 A1 EA200701689 A1 EA 200701689A1 EA 200701689 A EA200701689 A EA 200701689A EA 200701689 A EA200701689 A EA 200701689A EA 200701689 A1 EA200701689 A1 EA 200701689A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkyl
acid derivatives
aryl
hydrogen
betulinic acid
Prior art date
Application number
EA200701689A
Other languages
English (en)
Other versions
EA013158B1 (ru
Inventor
Рама Мукерджи
Санджай Кумар Сривастава
Мохаммад Джамшед Ахмед Сиддикуи
Ману Джагги
Ану Т. Сингх
Ананд Вардхан
Манодж Кумар Синг
Правин Раджендран
Хемант Кумар Джаджу
Ананд К. Бурман
Вивек Кумар
Нидхи Рани
Шив Кумар Агарвал
Original Assignee
Дабур Фарма Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дабур Фарма Лимитед filed Critical Дабур Фарма Лимитед
Publication of EA200701689A1 publication Critical patent/EA200701689A1/ru
Publication of EA013158B1 publication Critical patent/EA013158B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Изобретение относится к новым производным бетулиновой кислоты формулы (I), где R означает С(=СН)СНили СН(СН); Rвместе с соседней карбонильной группой образует карбоновую кислоту, сложный эфир или амид карбоновой кислоты или замещенный амид; Rи Rозначают водород или арил, при условии, что оба независимо не означают водород или алкил, или Rи R, соединенные вместе, образуют арильное кольцо, необязательно, замещенное группой X, где группу Х выбирают из галогена, алкила, циано, нитро, алкокси, амино или замещенного амина; Y означает N или О; и Rотсутствует, когда Y означает О, и Rозначает водород, алкил или арилалкил, когда Y означает N, пригодным для торможения роста раковых клеток.
EA200701689A 2005-02-09 2005-12-29 Новые производные бетулиновой кислоты EA013158B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN265DE2005 2005-02-09
PCT/IN2005/000445 WO2006085334A2 (en) 2005-02-09 2005-12-29 Novel betulinic acid derivatives a-ring-condensed to a heterocyclic group

Publications (2)

Publication Number Publication Date
EA200701689A1 true EA200701689A1 (ru) 2008-02-28
EA013158B1 EA013158B1 (ru) 2010-02-26

Family

ID=36793451

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701689A EA013158B1 (ru) 2005-02-09 2005-12-29 Новые производные бетулиновой кислоты

Country Status (12)

Country Link
US (1) US8022055B2 (ru)
EP (1) EP1858910B1 (ru)
KR (1) KR101068259B1 (ru)
AT (1) ATE486886T1 (ru)
AU (1) AU2005327442B2 (ru)
BR (1) BRPI0519948A2 (ru)
CA (1) CA2597300C (ru)
DE (1) DE602005024623D1 (ru)
EA (1) EA013158B1 (ru)
NZ (1) NZ560734A (ru)
WO (1) WO2006085334A2 (ru)
ZA (1) ZA200706393B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9062197B2 (en) * 2009-03-27 2015-06-23 Eastman Chemical Company Polyester blends
PL227790B1 (pl) 2015-08-13 2018-01-31 Slaski Univ Medyczny W Katowicach Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie.
RU2758376C2 (ru) 2017-09-14 2021-10-28 Феникс Байотекнолоджи, Инк. Способ и улучшенная нейропротекторная композиция для лечения неврологических патологических состояний
EP3681508A4 (en) 2017-09-14 2021-05-19 Phoenix Biotechnology, Inc. METHOD AND COMPOSITION FOR THE TREATMENT OF VIRAL INFECTION
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
SG11202105728YA (en) 2020-03-31 2021-11-29 Phoenix Biotechnology Inc Method and compositions for treating coronavirus infection

Also Published As

Publication number Publication date
EP1858910B1 (en) 2010-11-03
US20080293682A1 (en) 2008-11-27
EA013158B1 (ru) 2010-02-26
KR20070107717A (ko) 2007-11-07
AU2005327442B2 (en) 2011-09-01
DE602005024623D1 (de) 2010-12-16
KR101068259B1 (ko) 2011-09-28
WO2006085334A3 (en) 2007-06-14
CA2597300C (en) 2012-11-27
ZA200706393B (en) 2009-11-25
NZ560734A (en) 2010-09-30
US8022055B2 (en) 2011-09-20
AU2005327442A1 (en) 2006-08-17
WO2006085334A2 (en) 2006-08-17
ATE486886T1 (de) 2010-11-15
EP1858910A2 (en) 2007-11-28
CA2597300A1 (en) 2006-08-17
BRPI0519948A2 (pt) 2009-12-01

Similar Documents

Publication Publication Date Title
ES2543607T3 (es) Ciertas amidas sustituidas, método de obtención, y método de su uso
AR057023A1 (es) Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
WO2006109075A3 (en) Hydroxybenzamide derivatives and their use as inhibitors of hsp90
RS53061B (en) INHIBITORI PROTEIN KINAZE
HRP20080429T3 (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
EA200701689A1 (ru) Новые производные бетулиновой кислоты
RS53688B1 (en) 1,2,5-OXADIAZOLES AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS
DK1940789T3 (da) Fremgangsmåder og forbindelser til fremstilling af CC-1065-analoger
MX2011009034A (es) Formas de profarmaco de inhibidores de cinasa y su uso en la terapia.
BRPI0508464A (pt) sulfonilpirróis
TW200635585A (en) Monocyclic substituted methanones
MX2010000658A (es) Derivados de pirimidina 934.
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
ME01595B (me) Benzamidinska jedinjenja koja su korisna kao inhibitori histonske deacetilaze
EA200701779A1 (ru) Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии
EA201171328A1 (ru) Производное замещенного изохинолина
CY1107677T1 (el) Παραγωγα της 1-[indol-3-yl)carbonyl]piperazine
TR200705187T1 (tr) 2-Kromen hazırlanması için yeni yöntemler
BRPI0510335A (pt) composto heterocìclico
BR112013018732A2 (pt) novos derivados de amida de aril-benzocicloalquila
EA200700064A1 (ru) Способ получения эфиров 4,4-дифтор-3-оксобутановой кислоты
CO5660258A2 (es) Derivados de imidazol iii
EA200500237A1 (ru) Новый способ синтеза соединений 1,3-дигидро-2h-3-бензазепин-2-она и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
DK1694641T3 (da) Prostaglandinsyntese
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU